Delayed and Exaggerated Postprandial Complement Component 3 Response in Familial Combined Hyperlipidemia

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2002-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.0000014079.98335.72PMID 12006395
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure and expression of the C3 gene

  2004cited by this paper
• Plasma Acylation Stimulating Protein Concentration and Subcutaneous Adipose Tissue C3 mRNA Expression in Nondiabetic and Type 2 Diabetic Men

  2001cited by this paper
• Postprandial Increase of Complement Component 3 in Normolipidemic Patients With Coronary Artery Disease: Effects of Expanded-Dose Simvastatin

  2001cited by this paper
• Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes.

  2001cited by this paper
• Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.

  2001cited by this paper
• Serum C3 but Not Plasma Acylation-Stimulating Protein Is Elevated in Finnish Patients With Familial Combined Hyperlipidemia

  2001cited by this paper
• Replication of Linkage of Familial Combined Hyperlipidemia to Chromosome 1q With Additional Heterogeneous Effect of Apolipoprotein A-I/C-III/A-IV Locus: The NHLBI Family Heart Study

  2000cited by this paper
• In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia.

  2000cited by this paper
• Relationship of serum C3 complement with insulin resistance and coronary heart disease-cause, consequence or common antecedent?

  2000cited by this paper
• Coronary flow reserve in young men with familial combined hyperlipidemia.

  1999cited by this paper
• A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

  1999cited by this paper
• Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.

  1999cited by this paper
• Relationship between serum C3 levels and traditional risk factors for myocardial infarction.

  1998cited by this paper
• Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB

  1998cited by this paper
• The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers

  1998cited by this paper
• Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period.

  1998cited by this paper
• The adipocyte, fatty acid trapping, and atherogenesis.

  1998cited by this paper
• Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

  1997cited by this paper
• Serum complement and familial combined hyperlipidemia.

  1997cited by this paper
• Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia.

  1997cited by this paper
• Plasma acylation-stimulating protein in coronary artery disease.

  1997cited by this paper
• A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia.

  1997cited by this paper
• Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease.

  1996cited by this paper
• Two novel apolipoprotein A‐IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity

  1996cited by this paper
• Bioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference Statement.

  1996cited by this paper
• Interleukin 6 upregulates TNF-alpha-dependent C3-stimulating activity through enhancement of TNF-alpha specific binding on rat liver epithelial cells.

  1996cited by this paper
• INTERLEUKIN 6 UPREGULATES TNF-α-DEPENDENT C3-STIMULATING ACTIVITY THROUGH ENHANCEMENT OF TNF-α SPECIFIC BINDING ON RAT LIVER EPITHELIAL CELLS

  1996cited by this paper
• Validation of extracellular water determination by bioelectrical impedance analysis in growth hormone-deficient adults.

  1995cited by this paper
• Lipoprotein Lipase Association with Lipoproteins Involves Protein-Protein Interaction with Apolipoprotein B (*)

  1995cited by this paper
• Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.

  1994cited by this paper
• Association between genetic variation at the APO AI‐CIII‐AIV gene cluster and familial combined hyperlipidaemia

  1994cited by this paper
• The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure

  1994cited by this paper
• Impaired chylomicron remnant clearance in familial combined hyperlipidemia.

  1993cited by this paper
• The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis.

  1993cited by this paper
• Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.

  1993cited by this paper
• Familial combined hyperlipidaemia: 1973-1991.

  1992cited by this paper
• Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids.

  1992cited by this paper
• Proteolysis of human apolipoprotein B: effect on quantitative immunoturbidimetry.

  1990cited by this paper
• Regulation of hepatic synthesis of C3 and C4 during the acute‐phase response in the rat

  1989cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Short reports

  1980cited by this paper
• Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

  1973cited by this paper
• Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype.

  1973cited by this paper
• Family study of serum lipids and lipoproteins in coronary heart-disease.

  1973cited by this paper
• Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

  1970cited by this paper
• Human C'3: Evidence for the Liver as the Primary Site of Synthesis

  1969cited by this paper

• Plasma complement system markers and their association with cardiometabolic risk factors: an ethnic comparison of White European and Black African men.

  2025cites this paper
• The complement system in lipid-mediated pathologies

  2024cites this paper
• Acylation stimulating protein/C3adesArg in the metabolic states: role of adipocyte dysfunction in obesity complications

  2024cites this paper
• From complement to complosome in non‐alcoholic fatty liver disease: When location matters

  2023cites this paper
• The role of complement in nonalcoholic fatty liver disease

  2022influential citation
• Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study

  2021cites this paper
• Complement activation in polycystic ovary syndrome occurs in the postprandial and fasted state and is influenced by obesity and insulin sensitivity

  2020cites this paper
• Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink

  2018cites this paper
• Postprandial Lipid Response to High-Saturated and High-Monounsaturated Fat Meals in Normal-Weight or Overweight Women

  2018cites this paper
• The complement system is dysfunctional in metabolic disease: Evidences in plasma and adipose tissue from obese and insulin resistant subjects.

  2017cites this paper
• The complement system and cardiovascular disease : the CODAM study

  2016cites this paper
• Efecto del género y parámetros antropométricos en marcadores de estrés oxidativo e inflamación en situación postprandial

  2015cites this paper
• C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors

  2014cites this paper
• Postprandial lipemia as a cardiometabolic risk factor

  2014cites this paper
• Evaluation of acylation stimulating protein (ASP) and adipokines in relationship with determinants of obesity and its consequences

  2014cites this paper
• The complement system in human cardiometabolic disease.

  2014cites this paper
• The postprandial situation as a pro-inflammatory condition.

  2014cites this paper
• Acute Effects of Exogenous Hormone Administration on Postprandial Acylation Stimulating Protein Levels in Ovariectomized Rats after a Fat Load

  2014cites this paper
• Cardiovascular drugs and the risk of systemic autoimmune diseases : pharmacoepidemiological and experimental approaches

  2014cites this paper
• Influence of acute hyperlipidemia to adipocyte-derived hormones in lean normotensive and subjects with metabolic syndrome

  2014cites this paper
• Review article Postprandial lipemia as a cardiometabolic risk factor

  2014cites this paper
• Dyslipidemia in Obesity: Mechanisms and Potential Targets

  2013cites this paper
• Lipaemia, Inflammation and Atherosclerosis: Novel Opportunities in the Understanding and Treatment of Atherosclerosis

  2012cites this paper
• Novel Aspects of Nonfasting Lipemia in relation to Vascular Biology

  2012cites this paper
• Complement system and small HDL particles are associated with subclinical atherosclerosis in SLE patients.

  2012cites this paper
• Understanding Postprandial Inflammation and Its Relationship to Lifestyle Behaviour and Metabolic Diseases

  2011cites this paper
• Complement C3 and cleavage products in cardiometabolic risk.

  2011cites this paper
• Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese

  2010cites this paper
• Adipose tissue secreted factors in specific populations and metabolic states : implications for energy balance and metabolic health

  2010cites this paper
• Cell-mediated lipoprotein transport: a novel anti-atherogenic concept.

  2010cites this paper
• Mannose binding lectin deficiency and triglyceride-rich lipoprotein metabolism in normolipidemic subjects.

  2009cites this paper
• Metabolic syndrome: A review of emerging markers and management

  2009cites this paper
• Familial combined hyperlipidaemia: under - defined and under - diagnosed?

  2008cites this paper
• Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects

  2008cites this paper
• Paraoxonase 1 and Postprandial Lipemia

  2008cites this paper
• Complement activation in vascular remodeling and organ damage

  2008cites this paper
• The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers.

  2007cites this paper
• Síndrome de Prader-Willi como modelo de obesidad: Ghrelina, péptido YY, adiponectina y parámetros inflamatorios

  2007cites this paper
• Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date

  2007influential citation
• Chylomicron accelerates C3 tick‐over by regulating the role of Factor H, leading to overproduction of acylation stimulating protein

  2007cites this paper
• Postprandial inflammation and endothelial dysfuction.

  2007cites this paper
• Adipose targets for obesity drug development

  2006cites this paper
• Familial combined hyperlipidemia: the case of triglycerides

  2006cites this paper
• In silico Discovery of Genes Expressed in Liver, Kidney, Spleen and Small Intestine of Pigs

  2005cites this paper
• Visión actualizada de la hiperlipidemia familiar combinada aplicada a la mejora de su diagnóstico

  2005cites this paper
• Perfil diurno de triglicéridos en sujetos con hiperlipidemia familiar combinada de una población del sur de Europa

  2005cites this paper
• In vivo evidence of impaired peripheral fatty acid trapping in patients with human immunodeficiency virus-associated lipodystrophy.

  2005cites this paper
• Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes

  2005cites this paper
• Genetic lipoprotein disorders and coronary atherosclerosis

  2005cites this paper
• Metabolic dysregulation and interventions in type 2 diabetes mellitus and HIV-lipodystrophy

  2005cites this paper
• Evidence for a complex risk profile in obese postmenopausal Turkish women with hypertriglyceridaemia and elevated apolipoprotein B.

  2004cites this paper
• Free fatty acids exert a greater effect on ocular and skin blood flow than triglycerides in healthy subjects

  2004cites this paper
• Alcohol, nutrition and health maintenance: selected aspects

  2004cites this paper
• Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemia.

  2004cites this paper
• Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3.

  2004influential citation
• Diagnostic Criteria in Relation to the Pathogenesis of Familial Combined Hyperlipidemia

  2004cites this paper
• Gender Differences in Postprandial Ketone Bodies in Normolipidemic Subjects and in Untreated Patients With Familial Combined Hyperlipidemia

  2003cites this paper
• Postprandial lipaemia in familial combined hyperlipidaemia.

  2003cites this paper
• The Apolipoprotein AV Gene and Diurnal Triglyceridaemia in Normolipidaemic Subjects

  2003cites this paper
• Section IV: Lipid Modulators of Islet Function Update on Adipocyte Hormones Regulation of Energy Balance and Carbohydrate/Lipid Metabolism

  2003cites this paper
• Isoflavone effects on cardiovascular risk factors and arterial function Related review: Isoflavones: their effects on cardiovascular risk and functions (pp 3–8)

  2003cites this paper
• Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300201-JLR200

  2003cites this paper